Covered recipient · General Payments record
SAMUEL A GRAMPSAS
Allopathic & Osteopathic Physicians Urology
General Payments · PY2018–2024
$7,035.04
- Reported across 160 records
- CMS publication 2026-01-23
Financial relationships do not necessarily indicate an improper relationship; the data is open to interpretation.
How these totals are calculated
- The total is the sum of the General Payments records CMS published for the labeled program year(s), exactly as published. Nothing is estimated, weighted, or combined across categories.
- General Payments only. Research and Ownership/Investment are separate datasets and are never summed with these figures; amounts are kept separate per program year.
- Featured-page threshold (a presentation gate, not a judgment): records>=3 OR total>=100 (all years).
- Methodology & Data — sourcing, labeling, and limitations.
By nature of payment
PY2024 · sorted by reported total
| Nature of payment | Amount | Records |
|---|---|---|
| Food and Beverage | $1,095.74 | 16 |
By paying entity
PY2024 · sorted by reported total
| Paying entity | Amount | Records |
|---|---|---|
| UROGEN PHARMA, INC. | $362.91 | 3 |
| Smith & Nephew, Inc. | $310.45 | 6 |
| COLOPLAST CORP | $180.79 | 3 |
| Medtronic, Inc. | $161.45 | 1 |
| ConvaTec Inc. | $31.09 | 1 |
| Valencia Technologies Corporation | $28.42 | 1 |
| Integra LifeSciences Corporation | $20.63 | 1 |
By program year
All program years on this page · sorted by year
Payment records · PY2024 (16)
Sorted by paying entity, then date · as published by CMS
| Paying entity | Amount | Date | Nature of payment | Dispute status | Published | Record ID | Source |
|---|---|---|---|---|---|---|---|
| COLOPLAST CORP | $68.06 | 02/22/2024 | Food and Beverage | Undisputed | 01/23/2026 | 1117463695 | CMS |
| COLOPLAST CORP | $81.44 | 05/03/2024 | Food and Beverage | Undisputed | 01/23/2026 | 1117463739 | CMS |
| COLOPLAST CORP | $31.29 | 05/16/2024 | Food and Beverage | Undisputed | 01/23/2026 | 1117463753 | CMS |
| ConvaTec Inc. | $31.09 | 04/11/2024 | Food and Beverage | Undisputed | 01/23/2026 | 1151374480 | CMS |
| Integra LifeSciences Corporation | $20.63 | 07/10/2024 | Food and Beverage | Undisputed | 01/23/2026 | 1140131444 | CMS |
| Medtronic, Inc. | $161.45 | 11/22/2024 | Food and Beverage | Undisputed | 01/23/2026 | 1119294739 | CMS |
| Smith+Nephew, Inc. | $35.69 | 03/06/2024 | Food and Beverage | Undisputed | 01/23/2026 | 1149531124 | CMS |
| Smith+Nephew, Inc. | $85.36 | 04/24/2024 | Food and Beverage | Undisputed | 01/23/2026 | 1149531134 | CMS |
| Smith+Nephew, Inc. | $48.13 | 05/03/2024 | Food and Beverage | Undisputed | 01/23/2026 | 1149531130 | CMS |
| Smith+Nephew, Inc. | $46.54 | 09/13/2024 | Food and Beverage | Undisputed | 01/23/2026 | 1149531128 | CMS |
| Smith+Nephew, Inc. | $42.88 | 10/31/2024 | Food and Beverage | Undisputed | 01/23/2026 | 1149531126 | CMS |
| Smith+Nephew, Inc. | $51.85 | 11/22/2024 | Food and Beverage | Undisputed | 01/23/2026 | 1149531132 | CMS |
| UROGEN PHARMA, INC. | $135.46 | 05/03/2024 | Food and Beverage | Undisputed | 01/23/2026 | 1137918257 | CMS |
| UROGEN PHARMA, INC. | $114.39 | 09/19/2024 | Food and Beverage | Undisputed | 01/23/2026 | 1137918565 | CMS |
| UROGEN PHARMA, INC. | $113.06 | 11/08/2024 | Food and Beverage | Undisputed | 01/23/2026 | 1137918191 | CMS |
| Valencia Technologies Corporation | $28.42 | 05/29/2024 | Food and Beverage | Undisputed | 01/23/2026 | 1088809714 | CMS |
Source & provenance
- Dataset
- CMS Open Payments — General Payments
- Publisher of source data
- Centers for Medicare & Medicaid Services
- CMS publication date
- 2026-01-23
- Program years on this page
- 2018, 2019, 2020, 2021, 2022, 2023, 2024
- Source files
- Dataset page · Bulk file · PY2018 , PY2019 , PY2020 , PY2021 , PY2022 , PY2023 , PY2024
- Generated from
- OP_DTL_GNRL_PGYR2024_P01232026_01102026.csv
One page per canonical provider; split Profile_IDs are merged via Associated_Covered_Recipient_Profile_ID_1/_2 from the Covered Recipient Profile Supplement.
Corrections to the substance of a record route to CMS through its review-and-dispute process; errors in how this site mirrors or displays a record route to us. Both paths are described in Methodology & Data.